BioCentury | Jan 21, 2008
Clinical News

2PX: Phase II data

...In a double-blind, crossover, Norwegian Phase II trial in 84 patients, 2PX met the primary endpoint...
...topical 2PX or placebo for 4 weeks, followed by a 4-week crossover. Positive trends for 2PX...
...and total scores for pain relief and pain intensity. SantoSolve AS , Oslo, Norway Product: 2PX...
Items per page:
1 - 1 of 1